Jersy Jair Cardenas Salas

Jersy Jair Cardenas Salas
Fundación Jiménez Díaz | IIS-FJD · Servicio de Endocrinología y Nutrición

Bachelor of Medicine

About

26
Publications
2,415
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
76
Citations

Publications

Publications (26)
Article
Full-text available
Background and Objectives: Differentiating between hypovolemic (HH) and euvolemic hy-ponatremia (EH) is crucial for correct diagnosis and therapy, but can be a challenge. We aim to ascertain whether changes in serum creatinine (SC) can be helpful in distinguishing HH from EH. Materials and Methods: Retrospective analysis of patients followed in a m...
Article
Obesity is one of the most important health issues worldwide. According to the Mexican National Survey of Health and Nutrition 2018 “ENSANUT”, 76.8% of women and 73% of men who are 18 years or older are overweight or obese, and the majority are not well diagnosed. One of the greatest difficulties in order to diagnose this disease is the poor correl...
Preprint
Full-text available
BACKGROUND Hyponatremia is a frequent electrolytic disorder in hospitalized patients with Coronavirus Disease 2019 (COVID-19). Inflammatory status could be associated with hyponatremia in patients with COVID-19. We evaluate the hospital evolution of hyponatremia and inflammation markers in COVID-19 patients.METHODSA case-series of adult patients wi...
Article
Full-text available
Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of somatotropinomas, thyrotropinomas, and functioning and non-functioning gastroenteropancreatic neuroendocrine tumors. They should also be considered an effective and safe therapeutic alternative to corticotropinomas, gonadotropinomas, and prolactinomas resist...
Poster
Full-text available
This study reveals the usefulness of the serum Na-Creatinine relationship for the determination of volume status in hyponatremic patients. Available in: https://www.elsevier.es/es-revista-endocrinologia-diabetes-nutricion-13-pdf-X2530016419002510
Article
Full-text available
In patients with active acromegaly after pituitary surgery, somatostatin analogues are effective in controlling the disease and can even be curative in some cases. After treatment discontinuation, the likelihood of disease recurrence is high. However, a small subset of patients remains symptom-free after discontinuation, with normalized growth horm...
Article
Full-text available
Key Clinical Message Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be ruled out.
Article
Introduction: The use of Bisphosphonates could be a treatment option of osteoporosis secondary to primary hyperparathyroidism (OPHP) in patients not eligible or that refuse/reject surgery. Methods/design: We analysed data of 46 patients diagnosed of OPHP. Fourteen underwent surgery and 32 were treated with bisphosphonates at standard dose. Densitom...
Article
Full-text available
With a prevalence of Morbid Obesity of 1,2% of the Spanish population, the current criteria for Bariatric Surgery do not classify patients taking into consideration co-morbidities or functional status. We need new staging systems useful in predicting mortality and able to support prioritizing treatments. Applying Edmonton staging system to patients...
Conference Paper
Full-text available
ENFERMEDAD DE GRAVES-BASEDOW Y RESISTENCIA A HORMONAS TIROIDEAS Introducción: El síndrome de resistencia a hormonas tiroideas (RHT) es una alteración genética que se caracteriza por disminución de la sensibilidad tisular a las hormonas tiroideas (HT). Se han descrito mutaciones en el receptor de hormonas tiroideas alfa y beta, en el transportador d...
Article
Subcutaneous lipomas (SL) are the most common benign mesenchymal tumors with an estimated prevalence of 1%. They usually appear single, between 50-60 years of age, without gender differences. However, multiple lipomatosis (ML) occurs in 5-10% of patients, more frequently in men and almost 30% of them have family history of ML. Cytogenetic abnormali...

Network

Cited By